Demographic diversity of US-based participants in GSK-sponsored interventional clinical trials

por Reid, Michel M, Davis, Scott P, Henry, Ouzama N, Mathew, Ashwin A, McCallister, Scott, Nero, Taj T, Rabheru, Sanjit A, Sampson, Shani H, Vanderslice, Tracy F, Williams, Danaé T
Publicado 2023

P864: A PHASE 1 STUDY OF BELANTAMAB MAFODOTIN IN COMBINATION WITH STANDARD OF CARE IN NEWLY DIAGNOSED MULTIPLE MYELOMA: AN INTERIM ANALYSIS OF DREAMM-9

por Usmani, Saad Z, Mielnik, Michał, Min Byun, Ja, Alonso Alonso, Aránzazu, Abdallah, Al-Ola, Garg, Mamta, Quach, Hang, Min, Chang-Ki, Janowski, Wojciech, Miguel, Enrique Maria Ocio San, Weisel, Katja, Oriol, Albert, Sandhu, Irwindeep, Rodríguez-Otero, Paula, Ramasamy, Karthik, Egger, Jacqueline, Williams, Danaè, MA, Jie, Kaisermann, Morrys, Hus, Marek
Publicado 2023